Solid-phase supported radiolabeling of peptides
US-2024409578-A1 · Dec 12, 2024 · US
Substrate based PET imaging agents
US9005577B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9005577-B2 |
| Application number | US-43321109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 30, 2009 |
| Priority date | Apr 30, 2008 |
| Publication date | Apr 14, 2015 |
| Grant date | Apr 14, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present application is directed to radiolabeled imaging agents comprising a radiolabel, and a substrate, pharmaceutical compositions comprising radiolabeled imaging agents, and methods of using the radiolabeled imaging agents. The present application is further directed to methods of preparing the radiolabeled imaging agent. Such imaging agents can used in imaging studies, such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT).
First claim
Opening claim text (preview).
What is claimed is: 1. An imaging agent represented by the structure or a pharmaceutically acceptable salt thereof wherein RL is a radiolabel. 2. An imaging agent represented by the structure or a pharmaceutically acceptable salt thereof wherein RL is a radiolabel. 3. The imaging agent of claim 2 , wherein the radiolabel is 18 F. 4. The imaging agent of claim 1 , wherein the radiolabel is 18 F.
Assignees
Inventors
Classifications
- A61K51/088Primary
conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title
involving radioactive labelled substances · CPC title
Drugs for disorders of the alimentary tract or the digestive system · CPC title
Cysteine endopeptidases (3.4.22) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9005577B2 cover?
- The present application is directed to radiolabeled imaging agents comprising a radiolabel, and a substrate, pharmaceutical compositions comprising radiolabeled imaging agents, and methods of using the radiolabeled imaging agents. The present application is further directed to methods of preparing the radiolabeled imaging agent. Such imaging agents can used in imaging studies, such as Positron …
- Who is the assignee on this patent?
- Kolb Hartmuth C, Walsh Joseph C, Chen Kai, and 7 more
- What technology area does this patent fall under?
- Primary CPC classification A61K51/088. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).